Tag: Emirati Genome Program
UAE launches first genomics-driven clinical trial for Alzheimer’s
M42's Insights Research Organization and Solutions (IROS), in collaboration with the Department of Health – Abu Dhabi (DoH) and US-based Halia Therapeutics, has launched...
Abu Dhabi DoH signs MoU with Novartis to advance healthcare innovation
The Department of Health – Abu Dhabi (DoH) has signed a Memorandum of Understanding (MoU) with Novartis Middle East to explore collaboration in genomics...
M42, DoH Abu Dhabi study explores genetic risks in eye health
M42 has unveiled the results of a nationwide study conducted in partnership with the Department of Health – Abu Dhabi, showing that genomics can...
M42 strikes MoU with Uzbekistan Ministry of Health to advance genomics
Abu Dhabi-based M42, a global health leader, has signed a Memorandum of Understanding (MoU) with Uzbekistan’s Ministry of Health to launch 'Uzbek Genome Program',...
Abu Dhabi DoH & Novartis unite to advance genomics research
Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has signed a Memorandum of Understanding (MoU) with...
Emirati Genome Program unveils new visual identity
The Emirati Genome Program (EGP), one of the largest population genomic initiatives in the world, has launched a new visual identity, marking its efforts...
Emirati Genome Program, NMC open new collection center in Abu Dhabi
The Emirati Genome Program has added new collection centers through NMC Healthcare’s network in Abu Dhabi as part of the UAE Department of Health’s...
